ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,874Medicare Part D Prescriptions Filled, Including Refills

Rank: 27 out of 6969

$1.92M Total Retail Price of All Prescriptions

Rank: 33 out of 6969

561 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 561 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

27% of this provider’s 561 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 24,258 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

53 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 937 780 1 1
LEVOTHYROXINE SODIUM 788 630 2 5
FUROSEMIDE 760 634 3 10
GABAPENTIN 752 573 4 17
HYDROCODONE-ACETAMINOPHEN 624 373 S3 5 3
FAMOTIDINE 617 489 6 37
METOPROLOL TARTRATE 605 488 7 13
WARFARIN SODIUM 574 527 8 20
ZOLPIDEM TARTRATE 534 407 9 16
TRAMADOL HCL 484 407 10 27
CLOPIDOGREL 466 447 11 48
AMLODIPINE BESYLATE 460 419 12 4
METFORMIN HCL 435 298 13 7
DONEPEZIL HCL 429 391 14 32
JANUVIA 401 347 15 41
ALENDRONATE SODIUM 395 343 16 14
ALLOPURINOL 394 318 17 35
CARVEDILOL 386 344 18 25
OMEPRAZOLE 382 284 19 6
DIOVAN 380 379 20 26
NAMENDA 358 355 21 51
PLAVIX 354 330 22 68
FLUTICASONE PROPIONATE 344 269 23 24
TAMSULOSIN HCL 338 292 24 23
DIOVAN HCT 330 289 25 57
LOSARTAN POTASSIUM 329 275 26 12
MIRTAZAPINE 305 230 27 76
BENAZEPRIL HCL 302 240 28 18
SYMBICORT 290 229 29 149
ADVAIR DISKUS 288 245 30 45
GLIPIZIDE 286 220 31 21
CITALOPRAM HBR 264 234 32 34
DOXAZOSIN MESYLATE 262 226 33 74
GLIMEPIRIDE 234 204 34 44
FLUOCINONIDE 232 216 35 134
NIFEDIPINE ER 230 162 36 95
POTASSIUM CHLORIDE 225 200 37 30
LEVEMIR 225 168 37 232
PRAMIPEXOLE DIHYDROCHLORIDE 221 202 39 227
LISINOPRIL 220 181 40 2
RISPERIDONE 211 133 41 88
KLOR-CON 8 209 187 42 104
PRAVASTATIN SODIUM 208 166 43 19
LACTULOSE 201 131 44 131
QUETIAPINE FUMARATE 199 168 45 101
CARBIDOPA-LEVODOPA 199 177 45 119
PANTOPRAZOLE SODIUM 198 158 47 31
LANTUS 198 132 47 50
LOSARTAN-HYDROCHLOROTHIAZIDE 197 161 49 53
CLONIDINE HCL 197 152 49 59
ATORVASTATIN CALCIUM 194 183 51 11
CRESTOR 186 122 52 39
IBANDRONATE SODIUM 185 159 53 178
NOVOLIN R 184 148 54 161
DIVALPROEX SODIUM 182 126 55 103
FENOFIBRATE 180 119 56 63
ZETIA 162 137 57 98
GEMFIBROZIL 162 116 57 85
METHIMAZOLE 152 129 59 345
DIGOXIN 149 137 60 71
ABILIFY 145 96 61 173
LEVETIRACETAM 145 85 61 128
RANITIDINE HCL 144 125 63 46
ESCITALOPRAM OXALATE 137 126 64 93
HUMULIN R 136 98 65 223
SERTRALINE HCL 135 110 66 38
CYMBALTA 134 125 67 72
ISOSORBIDE MONONITRATE ER 132 125 68 81
ATENOLOL 131 117 69 9
NEXIUM 131 81 69 52
IPRATROPIUM BROMIDE 130 103 71 179
SINGULAIR 128 121 72 84
METOPROLOL SUCCINATE 128 105 72 22
PAROXETINE HCL 126 92 74 65
VENLAFAXINE HCL ER 120 115 75 150
VESICARE 120 84 75 163
ALBUTEROL SULFATE 119 109 77 123
LOVAZA 108 107 78 77
LEVOFLOXACIN 103 88 79 109
DILTIAZEM 24HR CD 102 87 80 191
SEROQUEL 101 77 81 205
EXELON 98 97 82 157
SPIRIVA 97 81 83 66
OLANZAPINE 94 68 84 139
FINASTERIDE 93 85 85 80
SPIRONOLACTONE 92 54 86 102
ATELVIA 92 92 86 111
AZITHROMYCIN 91 77 88 42
GLYBURIDE-METFORMIN HCL 83 71 R 89 92
HYDRALAZINE HCL 83 66 89 106
AVODART 80 66 91 108
GLYBURIDE 78 60 R 92 54
AMITIZA 74 74 93 254
AMLODIPINE BESYLATE-BENAZEPRIL 73 61 94 91
FLUOXETINE HCL 73 61 94 43
INSULIN SYRINGE 68 40 96 60
LEVEMIR FLEXPEN 67 54 97 253
LIPITOR 67 62 97 89
METOCLOPRAMIDE HCL 64 52 99 136
AMIODARONE HCL 63 44 100 184
TRIAMCINOLONE ACETONIDE 63 61 100 55
BENZTROPINE MESYLATE 63 21 R 100 177
ACTONEL 61 37 103 115
NASONEX 60 41 104 144
PROPYLTHIOURACIL 60 55 104 420
EVOXAC 60 35 104 565
MONTELUKAST SODIUM 59 59 107 151
HYDROXYZINE HCL 58 57 R 108 159
PROAIR HFA 56 53 109 33
MEGESTROL ACETATE 56 52 R 109 129
SURE COMFORT 55 45 111 263
PATADAY 54 47 112 213
CELEBREX 54 54 112 67
TRICOR 54 0 112 143
ACTOS 53 50 115 61
BONIVA 52 43 116 198
CIPROFLOXACIN HCL 52 43 116 64
MECLIZINE HCL 51 51 118 100
ROPINIROLE HCL 51 38 118 162
NOVOFINE 32 50 36 120 522
HALOPERIDOL 50 15 120 244
TERAZOSIN HCL 50 50 120 49
MISOPROSTOL 50 29 120 292
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.